康普顿：2025年前三季度净利润约5476万元

Group 1 - Company Compton reported a revenue of approximately 753 million yuan for the first three quarters of 2025, a year-on-year decrease of 10.85% [1] - The net profit attributable to shareholders was approximately 54.76 million yuan, reflecting a year-on-year decline of 4.79% [1] - Basic earnings per share were 0.21 yuan, down 8.7% compared to the previous year [1] Group 2 - As of the report date, Compton's market capitalization stood at 4 billion yuan [2] - The Chinese innovative drug sector has seen significant overseas licensing sales totaling 80 billion US dollars this year [2] - There is a contrast in the biopharmaceutical secondary market's activity compared to the primary market, which is experiencing a fundraising slowdown [2]